2022.11.9 Axil Capital Launches its Second Life Science Fund (ALHF II)
Axil Capital announced today the launch of Axil Life Science & Healthcare Fund II (“ALHF II”)
As with ALHF I, ALHF II will focus on investing and supporting life science and health-tech startups by leveraging its industry expertise and global network. The fund aims to produce world-class companies from Japan by liaising with the global venture ecosystem and enabling the venture managers to adopt a global perspective focused on commercial success.
Axil Life Science & Healthcare Fund II Investment Limited Partnership (ALHF II L.P.)
Axil Capital Partners II Limited Liability Partnership
Biopharmaceutical, Life Science, Medical Technology and Healthcare Technology
Primarily Japan, with diversification across U.S., EU and Asia
Diversified investments from seed/early to middle/later
Axil Capital Advisors K.K.
Nittochi Nishi-shinbashi Bldg. 7F
Minato-ku, Tokyo 105-0003, JAPAN
© Axil Capital All Rights Reserved